Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy

View source ↗

Summary

An observational study evaluating the efficacy of sustained Qutenza (capsaicin 8% patch) use in painful diabetic peripheral neuropathy; the trial is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

Sponsor: Averitas Pharma, Inc. | Conditions: Peripheral Diabetic Neuropathy, Painful Diabetic Neuropathy | Status: ACTIVE_NOT_RECRUITING